Lista de obras -

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

scientific article published on 26 May 2016

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

artículo científico publicado en 2009

A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy ⬇️

artículo científico publicado el 13 de octubre de 2010

A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

artículo científico publicado en 2012

A gamma camera count rate saturation correction method for whole-body planar imaging

artículo científico publicado en 2010

A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy ⬇️

artículo científico publicado el 1 de junio de 2011

A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry ⬇️

artículo científico publicado el 15 de junio de 2012

An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer

artículo científico publicado en 2008

Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy

artículo científico publicado en 2010

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen

artículo científico publicado en 2015

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

artículo científico publicado en 2008

Calculation of the biological effective dose for piecewise defined dose-rate fits

artículo científico publicado en 2009

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent

artículo científico publicado en 2018

Comparative Dosimetry for 68Ga-DOTATATE: Impact of using Updated ICRP phantoms, S values and Tissue Weighting Factors

artículo científico publicado en 2018

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer

artículo científico publicado en 2016

Depth-dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry.

artículo científico publicado en 2016

Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy

artículo científico publicado en 2014

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma

artículo científico publicado en 2009

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

artículo científico publicado en 2018

Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan

artículo científico publicado en 2008

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

artículo científico publicado en 2008

Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical data

artículo científico publicado en 2014

Fine-Resolution Voxel S Values for Constructing Absorbed Dose Distributions at Variable Voxel Size ⬇️

artículo científico publicado el 16 de septiembre de 2010

Human Biodistribution and Radiation Dosimetry of 82Rb ⬇️

artículo científico publicado el 16 de septiembre de 2010

Improved dose–volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters ⬇️

artículo científico publicado el 7 de mayo de 2013

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

artículo científico publicado en 2015

Modelling and Dosimetry for Alpha-Particle Therapy ⬇️

artículo científico publicado el 1 de julio de 2011

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

artículo científico

Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates

artículo científico publicado en 2015

Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab ⬇️

artículo científico publicado el 1 de diciembre de 2010

Quantitative impact of changes in marrow cellularity, skeletal size, and bone mineral density on active marrow dosimetry based upon a reference model.

artículo científico publicado en 2017

Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma ⬇️

artículo científico publicado el 5 de agosto de 2013

Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.

artículo científico publicado en 2009

Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer

artículo científico publicado en 2017

Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.

artículo científico publicado en 2013

Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy

artículo científico publicado en 2014

Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry

artículo científico publicado en 2015

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

artículo científico publicado en 2012

Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma

artículo científico publicado en 2010

Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody ⬇️

artículo científico publicado el 19 de julio de 2013

Three-dimensional imaging-based radiobiological dosimetry

scientific article published on September 2008

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry

artículo científico publicado en 2007

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer ⬇️

artículo científico publicado el 12 de abril de 2011

Three‐dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy ⬇️

artículo científico publicado el 1 de octubre de 2012

Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma ⬇️

artículo científico publicado el 17 de enero de 2012

Lista de obras de

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy ⬇️

A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

A gamma camera count rate saturation correction method for whole-body planar imaging

A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy ⬇️

A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry ⬇️

An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer

Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

Calculation of the biological effective dose for piecewise defined dose-rate fits

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent

Comparative Dosimetry for 68Ga-DOTATATE: Impact of using Updated ICRP phantoms, S values and Tissue Weighting Factors

Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer

Depth-dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry.

Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical data

Fine-Resolution Voxel S Values for Constructing Absorbed Dose Distributions at Variable Voxel Size ⬇️

Human Biodistribution and Radiation Dosimetry of 82Rb ⬇️

Improved dose–volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters ⬇️

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

Modelling and Dosimetry for Alpha-Particle Therapy ⬇️

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates

Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab ⬇️

Quantitative impact of changes in marrow cellularity, skeletal size, and bone mineral density on active marrow dosimetry based upon a reference model.

Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma ⬇️

Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.

Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer

Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.

Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy

Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma

Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody ⬇️

Three-dimensional imaging-based radiobiological dosimetry

Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer ⬇️

Three‐dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy ⬇️

Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma ⬇️